CENTENE CORP
For the period ended Mar 31, 2025. Filed Apr 25, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 25, 2025
CNC$69.74-6.0%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024
CONSOLIDATED BALANCE SHEETS
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $14,815 | $14,063 |
| Premium and trade receivables | 22,436 | 19,713 |
| Short-term investments | 2,472 | 2,622 |
| Other current assets | 1,565 | 1,601 |
| Total current assets | 41,288 | 37,999 |
| Long-term investments | 18,268 | 17,429 |
| Restricted deposits | 1,409 | 1,390 |
| Property, software and equipment, net | 2,044 | 2,067 |
| Goodwill | 17,558 | 17,558 |
| Intangible assets, net | 5,236 | 5,409 |
| Other long-term assets | 1,241 | 593 |
| Total assets | $87,044 | $82,445 |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Medical claims liability | $19,911 | $18,308 |
| Accounts payable and accrued expenses | 13,948 | 13,174 |
| Return of premium payable | 2,403 | 2,008 |
| Unearned revenue | 869 | 661 |
| Current portion of long-term debt | 12 | 110 |
| Total current liabilities | 37,143 | 34,261 |
| Long-term debt | 18,308 | 18,423 |
| Deferred tax liability | 708 | 684 |
| Other long-term liabilities | 2,866 | 2,567 |
| Total liabilities | 59,025 | 55,935 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interests | 12 | 10 |
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.001 par value; authorized 800,000 shares; 622,511 issued and 497,518 outstanding at March 31, 2025, and 620,195 issued and 495,907 outstanding at December 31, 2024 | 1 | 1 |
| Additional paid-in capital | 20,631 | 20,562 |
| Accumulated other comprehensive (loss) | (337) | (504) |
| Retained earnings | 16,659 | 15,348 |
| Treasury stock, at cost (124,993 and 124,288 shares, respectively) | (9,038) | (8,997) |
| Total Centene stockholders' equity | 27,916 | 26,410 |
| Nonredeemable noncontrolling interest | 91 | 90 |
| Total stockholders' equity | 28,007 | 26,500 |
| Total liabilities, redeemable noncontrolling interests and stockholders' equity | $87,044 | $82,445 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.